Raloxifene for breast cancer prevention: an NWHN analysis
Tagged :
Print 
Text Size: Normal / Medium / Large
Printer-friendly versionResource Language:
English
Media Type:
Online
Argues that the breast cancer benefit of raloxifene may only be useful to a very small number of women.
Available From:
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.